RACE 3 long-term results show fading benefit of targeted therapies in AF and HF Presented ByProf. Michiel Rienstra, University Medical Center Groningen, the Netherlands TrialRACE 3 ConferenceEHRA 2021 TypePeer-reviewed article 16 June 2021 13:07